[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cellectis S.A. ADR (CLLS)

Cellectis S.A. ADR (CLLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Cellectis S.A. ADR 8 RUE DE LA CROIX JARRY PARIS LLE-DE-FRANCE I0 75013 FRA

www.cellectis.com Employees: 229 P: 33-1-81-69-16-00 F: +33 181691606

Sector:

Medical

Description:

Cellectis SA is a gene-editing company. The company focused on developing immunotherapies based on gene edited engineered CAR-T cells. Cellectis SA is based in Paris, France.

Key Statistics

Overview:

Market Capitalization, $K 386,305
Enterprise Value, $K 409,245
Shares Outstanding, K 100,339
Float, K 83,873
% Float 83.59%
Short Interest, K 383
Short Float 0.38%
Days to Cover 7.76
Short Volume Ratio 0.48
% of Insider Shareholders 16.41%
% of Institutional Shareholders 63.90%

Financials:

Annual Sales, $ 79,590 K
Annual Net Income, $ -67,590 K
Last Quarter Sales, $ 12,210 K
Last Quarter Net Income, $ -26,320 K
EBIT, $ -33,080 K
EBITDA, $ -13,020 K

Growth:

1-Year Return 151.63%
3-Year Return 121.26%
5-Year Return -75.15%
5-Year Revenue Growth -3.48%
5-Year Earnings Growth 64.92%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.26 on 03/19/26
Next Earnings Date 05/11/26 [--]
Earnings Per Share ttm -0.67
EPS Growth vs. Prev Qtr -2,700.00%
EPS Growth vs. Prev Year -62.50%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

CLLS Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -69.38%
Return-on-Assets % -19.51%
Profit Margin % -84.92%
Debt/Equity 1.11
Price/Sales 4.87
Price/Cash Flow N/A
Price/Book 5.10
Book Value/Share 0.76
Interest Coverage -0.33
60-Month Beta 2.94
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.